Inventor
Mark E. Layton
Inventor
Harleysville, PA, US
Overview
Patents· 23 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds39%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
A61KPreparations for medical, dental or toiletry purposes20%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
PatentTitleYear
10,968,210Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels202110,519,147Diamino-alkylamino-linked arylsulfonamide compounds with selective activity in voltage-gated sodium channels201910,442,778N1-phenylpropane-1,2-diamine compounds with selective activity in voltage-gated sodium channels20199,624,208'Benzoxazolinone compounds with selective activity in voltage-gated sodium channels'20179,586,968'Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels'20179,388,179'N-substituted indazole sulfonamide compounds with selective activity in voltage-gated sodium channels'20169,315,518'Imidazopyridin-2-one derivatives'20169,273,040'Benzoxazolinone compounds with selective activity in voltage-gated sodium channels'20169,108,937'Positive allosteric modulators of mGluR2'20159,062,059'Pyrimidine PDE10 inhibitors'20158,993,779'Positive allosteric modulators of MGLUR2'20158,952,005'Substituted 1,3-benzothiazol-2(3H)-ones and [1,3]thiazolo[5,4-B]pyridin-2(1H)-ones as positive allosteric modulators of mGluR2'20158,765,784'Positive allosteric modulators of MGLUR2'20148,536,193'Inhibitors of AKT activity'20138,481,503'Combination cancer therapy with an AKT inhibitor and other anticancer agents'20138,288,407'Substituted naphthyridine compounds as inhibitors of Akt activity'20128,207,169'Substituted [1,2,4]triazolo[4′,3′:1,6]pyrido[2,3-b]pyrazines of the formula D'20128,168,652'Inhibitors of AKT activity'20128,008,317'Inhibitors of akt activtiy'20117,910,561'Inhibitors of Akt activity'20117,589,068'Inhibitors of Akt activity'20097,576,209'Inhibitors of Akt activity'20097,452,893'4-cycloakylaminopyrazolo pyrimidine NMDA/NR2B antagonists'2008Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2008–2021Based in Harleysville, PA, US· patent location history
2011–2021Patents assigned to MERCK SHARP & DOHME (19)· patent assignee history
2012–2021Patents assigned to LAYTON MARK E (14)· patent assignee history
2012–2019Patents assigned to KELLY III MICHAEL J (4)· patent assignee history
2014–2016Patents assigned to PERO JOSEPH E (4)· patent assignee history
2016–2021Patents assigned to ROECKER ANTHONY J (4)· patent assignee history
2017Based in West Point, PA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 19 | 2011–2021 |
| LAYTON MARK Eself | 14 | 2012–2021 |
| KELLY III MICHAEL J | 4 | 2012–2019 |
| PERO JOSEPH E | 4 | 2014–2016 |
| ROECKER ANTHONY J | 4 | 2016–2021 |
Locations
| Location | Patents | Span |
|---|---|---|
| Harleysville, Pennsylvania, US | 22 | 2008–2021 |
| West Point, Pennsylvania, US | 1 | 2017 |